Praxis Precision Medicines to Present at 2022 Wedbush PacGrow Healthcare Conference

BOSTON, Aug. 03, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in the “Got My Mind Set On You – Advancing Novel Epilepsy Targets” panel at the 2022 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 10, 2022 at 12:35 p.m. ET.

The panel chat will be available via live webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. A replay of the webcast will be available on Praxis’ website for 30 days following the event.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from genetic epilepsies to both rare and more prevalent neurological disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio with multiple programs, including product candidates across movement disorders, epilepsy and psychiatric disorders, with three clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.

CONTACT: Investor Contact:
Alex Kane
Praxis Precision Medicines
investors@praxismedicines.com
617-300-8481

Media Contact:
Ian Stone
Canale Communications
Ian.stone@canalecomm.com
619-849-5388

Staff

Recent Posts

Public Health Software Pioneer Chexout Evolves into Aveva Public Health Solutions, Unveiling a Dynamic Rebranding Initiative

Aveva's Renaming Reflects Expanded Public Health Technology Offerings, Signals Next Phase of Growth VIENNA, Va.,…

16 seconds ago

Medasense Announces a Strategic Agreement With Global Medical Company, Nihon Kohden Corporation

RAMAT GAN, Israel, June 26, 2024 /PRNewswire/ -- Medasense, a global leader in pain monitoring…

19 seconds ago

Metalenses: IDTechEx Asks if They Are the New Key to Computer Vision

BOSTON, June 26, 2024 /PRNewswire/ -- Refractive lenses are one of humanity's oldest and most…

21 seconds ago

Blockchain Technology in Healthcare Market: Security Demand Propels Growth to $9706.49M by 2031 | SkyQuest Technology

WESTFORD, Mass., June 26, 2024 /PRNewswire/ -- According to SkyQuest, the Blockchain Technology in Healthcare Market…

26 seconds ago

AvaSure Named to AVIA Marketplace’s 2024 Top Smart Rooms Companies

BELMONT, Mich., June 26, 2024 /PRNewswire/ -- AvaSure, a market leader in acute virtual care, announced…

30 seconds ago